Ruiting Guo

522 total citations
11 papers, 199 citations indexed

About

Ruiting Guo is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ruiting Guo has authored 11 papers receiving a total of 199 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 3 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ruiting Guo's work include Hemoglobinopathies and Related Disorders (5 papers), RNA modifications and cancer (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Ruiting Guo is often cited by papers focused on Hemoglobinopathies and Related Disorders (5 papers), RNA modifications and cancer (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). Ruiting Guo collaborates with scholars based in United States, France and China. Ruiting Guo's co-authors include Jihui Jia, Yundong Sun, Zhifang Liu, Jorge Pereira, Mark C. Walters, Alexis A. Thompson, Gyan Pareek, Joseph Renzulli, Dragan Golijanin and Fang Ma and has published in prestigious journals such as Blood, Cell Death and Disease and American Journal of Hematology.

In The Last Decade

Ruiting Guo

11 papers receiving 198 citations

Peers

Ruiting Guo
Lee Silcock United Kingdom
Arne Trummer Germany
Maliha Nusrat United States
Jee‐Soo Lee South Korea
Leah Preus United States
Ruiting Guo
Citations per year, relative to Ruiting Guo Ruiting Guo (= 1×) peers Hongxia Yao

Countries citing papers authored by Ruiting Guo

Since Specialization
Citations

This map shows the geographic impact of Ruiting Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruiting Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruiting Guo more than expected).

Fields of papers citing papers by Ruiting Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruiting Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruiting Guo. The network helps show where Ruiting Guo may publish in the future.

Co-authorship network of co-authors of Ruiting Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Ruiting Guo. A scholar is included among the top collaborators of Ruiting Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruiting Guo. Ruiting Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Guo, Ruiting, Xixi Cui, Xue Li, et al.. (2022). CircMAN1A2 is upregulated by Helicobacter pylori and promotes development of gastric cancer. Cell Death and Disease. 13(4). 409–409. 34 indexed citations
2.
Kanter, Julie, Alexis A. Thompson, Francis J. Pierciey, et al.. (2022). Lovo‐cel gene therapy for sickle cell disease: Treatment process evolution and outcomes in the initial groups of the HGB‐206 study. American Journal of Hematology. 98(1). 11–22. 63 indexed citations
4.
Hongeng, Suradej, Alexis A. Thompson, Janet L. Kwiatkowski, et al.. (2021). Efficacy and Safety of Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-thalassemia) Gene Therapy in 60 Patients with Transfusion-Dependent β-Thalassemia (TDT) Followed for up to 6 Years Post-Infusion. Transplantation and Cellular Therapy. 27(3). S1–S1. 1 indexed citations
5.
Kwiatkowski, Janet L., Franco Locatelli, Mark C. Walters, et al.. (2021). Improvement in Health-Related Quality of Life Following Treatment with Betibeglogene Autotemcel in Patients with Transfusion-Dependent β-Thalassemia Enrolled in Phase 3 Studies. Blood. 138(Supplement 1). 3085–3085. 3 indexed citations
7.
Jia, Wenxiao, Fang Ma, Xue Li, et al.. (2019). <p>Long noncoding RNA THAP9-AS1 is induced by <em>Helicobacter pylori</em> and promotes cell growth and migration of gastric cancer</p>. OncoTargets and Therapy. Volume 12. 6653–6663. 26 indexed citations
8.
Ma, Fang, Xue Li, Juchao Ren, et al.. (2019). Downregulation of eukaryotic translation initiation factor 3b inhibited proliferation and metastasis of gastric cancer. Cell Death and Disease. 10(9). 623–623. 22 indexed citations
9.
Brito, Joseph, Jorge Pereira, Daniel M. Moreira, et al.. (2018). The association of lymph node dissection with 30-day perioperative morbidity among men undergoing minimally invasive radical prostatectomy: analysis of the National Surgical Quality Improvement Program (NSQIP). Prostate Cancer and Prostatic Diseases. 21(2). 245–251. 6 indexed citations
10.
Pereira, Jorge, Dragan Golijanin, Gyan Pareek, et al.. (2017). The association of age with perioperative morbidity and mortality among men undergoing radical prostatectomy. Urologic Oncology Seminars and Original Investigations. 36(4). 157.e7–157.e13. 15 indexed citations
11.
Pereira, Jorge, Joseph Renzulli, Gyan Pareek, et al.. (2017). Perioperative Morbidity of Open Versus Minimally Invasive Partial Nephrectomy: A Contemporary Analysis of the National Surgical Quality Improvement Program. Journal of Endourology. 32(2). 116–123. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026